Health

Scrapped Covid vaccine deal with Valneva cost UK taxpayers £358m


A spokesman for Valneva said the firm was “exploring options for its Almeida manufacturing facility in Livingston, initially built to produce its Covid-19 vaccine, including a possible sale or a repurposing to produce its vaccine for Japanese Encephalitis, and its chikungunya vaccine, if approved”.



READ SOURCE

This website uses cookies. By continuing to use this site, you accept our use of cookies.